News Headlines

  1. Mycenax And SPERA PHARMA Forge Strategic Alliance To Streamline ADC Drug Substance And Drug Product Manufacturing Services 9/18/2025

    Mycenax Biotech Inc. (TWO:4726), a leading biologics CDMO based in Taiwan, today announced strategic alliance with SPERA PHARMA Inc., a Japan-based expert in pharmaceutical Chemistry, Manufacturing, and Controls (CMC).

  2. GSK To Invest $30B In R&D And Manufacturing In The United States Over Next 5 Years 9/17/2025

    GSK plc today announced plans to invest $30B across the United States in research and development and supply chain infrastructure over the next five years.

  3. Wheeler Bio And MindImmune Therapeutics Sign CDMO Partnership Agreement To Support MindImmune's Lead Alzheimer's Prevention Program, MITI-101 9/17/2025

    Wheeler Bio, a U.S.-based contract development and biomanufacturing organization (CDMO), today announced it has entered into an agreement with MindImmune Therapeutics, a biopharmaceutical company focused on neuroinflammation and Alzheimer's disease.

  4. Abzena Enhances AbZelectPRO™ Cell Line Offering With New GS Knockout Platforms 9/16/2025
  5. Piramal Pharma Solutions Augments Formulation Capabilities With The Addition Of New Korsch XM-12 Bilayer Tablet Press At Its Morpeth, UK Facility 9/16/2025

    Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is excited to announce its recent acquisition of a state-of-the-art Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK.

  6. ProBioGen To Lead GMP Manufacturing Operations At Berlin Center For Gene And Cell Therapies (BC GCT) 9/16/2025

    ProBioGen and the Berlin Institute of Health at Charité (BIH) announced today that ProBioGen has been selected to operate the process development and good manufacturing practice (GMP) production facility for Advanced Therapy Medicinal Products (ATMPs) at the Berlin Center for Gene and Cell Therapies (BC GCT), a joint project of Charité –Universitätsmedizin Berlin, Bayer AG and Berlin Institute of Health at Charité (BIH).

  7. Lilly Announces Plans To Build $5B Manufacturing Facility In Virginia 9/16/2025

    Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County.

  8. Causaly Introduces First Agentic AI Platform Built For Life Sciences Research And Development 9/16/2025

    Causaly today introduced Causaly Agentic Research, an agentic AI breakthrough that delivers the transparency and scientific rigor that life sciences research and development demands.

  9. Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement For Single Antibody 9/15/2025

    Biocytogen Pharmaceuticals (Beijing) Co., Ltd. a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that ADC therapeutics developer, Tubulis has exercised an exclusive license for the global development and commercialization of a fully human antibody developed by Biocytogen.

  10. Made Scientific And Basilard BioTech Announce Technology Partnership To Advance Ex Vivo Gene Delivery For T Cell And iPSC Therapies 9/15/2025

    Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel delivery technologies for cell and gene therapy, today announced a strategic collaboration to accelerate the development and translation of Basilard BioTech's nanomechanical gene delivery platform, Celletto™.